Heart drug combo safety test begins
NCT ID NCT07431294
Summary
This study aims to check if it's safe for people with stable coronary artery disease to use their usual nitroglycerin spray while taking a new investigational drug called nurandociguat. Researchers want to see how these two drugs, which both work to widen blood vessels, interact in the body and if taking them together causes side effects like low blood pressure. The trial will involve 36 participants and is an early safety check before larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STABLE CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Comac Medical | Phase I Clinical Research Unit
Sofia, Sofia City Province, 1000, Bulgaria
-
Deutsches Herzzentrum der Charité (DHZC) - Klinik für Kardiologie, Angiologie und Intensivmedizin CVK
Berlin, 13353, Germany
-
SocraTec R&D Erfurt-Clinical Pharmacology Unit
Erfurt, 99084, Germany
-
UK Bonn Institut für Klinische Chemie und Klinische Pharmakologie, Phase I Einheit und Arzneimitteltherapiesicherheit
Bonn, 53127, Germany
-
Universitätsklinikum Heidelberg - Zentrum für Innere Medizin, Abteilung Klinische Pharmakologie und Pharmakoepidemologie
Heidelberg, 69120, Germany
Conditions
Explore the condition pages connected to this study.